Media coverage about Biogen (NASDAQ:BIIB) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Biogen earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave news stories about the biotechnology company an impact score of 48.3115664476984 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Here are some of the news stories that may have effected Accern’s analysis:
Get Biogen alerts:
Biogen (BIIB) Expected to Post Quarterly Sales of $3.24 Billion (americanbankingnews.com) Biogen Inc (NASDAQ:BIIB): Does The Earnings Decline Make It An Underperformer? (finance.yahoo.com) 5 Trade Ideas For Monday: AMTD, BIIB, DEO, FITB, TECK (investing.com) $5.29 EPS Expected for Biogen (BIIB) This Quarter (americanbankingnews.com) Biogen (BIIB) Upgraded by ValuEngine to “Hold” (americanbankingnews.com)
Shares of Biogen traded up $5.45, reaching $281.51, during midday trading on Wednesday, according to MarketBeat Ratings. 1,514,169 shares of the company’s stock were exchanged, compared to its average volume of 1,729,786. Biogen has a 52-week low of $276.94 and a 52-week high of $281.57. The firm has a market cap of $59.58 billion, a price-to-earnings ratio of 12.91, a PEG ratio of 1.65 and a beta of 0.84. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.95 and a current ratio of 3.23.
Best Biotech Stocks To Invest In Right Now: Luby's, Inc.(LUB)
Advisors’ Opinion:
- [By Max Byerly]
Headlines about Luby’s (NYSE:LUB) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Luby’s earned a news impact score of 0.10 on Accern’s scale. Accern also gave news coverage about the restaurant operator an impact score of 47.2262144037183 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers
Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent
Best Biotech Stocks To Invest In Right Now: Steelcase Inc.(SCS)
Advisors’ Opinion:
- [By Ethan Ryder]
SpeedCash (CURRENCY:SCS) traded 13.6% lower against the dollar during the 1 day period ending at 10:00 AM ET on May 4th. One SpeedCash coin can now be purchased for approximately $2.71 or 0.00028080 BTC on major exchanges including YoBit, Cryptohub, Trade Satoshi and Crex24. During the last seven days, SpeedCash has traded 201.8% higher against the dollar. SpeedCash has a total market capitalization of $1.26 million and $26,755.00 worth of SpeedCash was traded on exchanges in the last 24 hours.
- [By Max Byerly]
SpeedCash (SCS) is a coin. SpeedCash’s total supply is 476,918 coins and its circulating supply is 467,791 coins. The Reddit community for SpeedCash is /r/SpeedCash and the currency’s Github account can be viewed here. SpeedCash’s official Twitter account is @SpeedCashMedia. SpeedCash’s official website is www.scash.ml.
- [By Stephen Mack]
Jim Hackett spent two decades as CEO of Michigan-based office furniture company Steelcase Inc. (NYSE: SCS). When he took over, the American workplace was shifting away from cubicles, and the company looked on the verge of extinction, with $70 million in annual losses.
- [By Logan Wallace]
Here are some of the media stories that may have impacted Accern’s rankings:
Get Steelcase alerts:
Vida Health Expands Platform to Tackle Comorbidities (prweb.com) Zacks: Brokerages Expect Steelcase (SCS) Will Announce Quarterly Sales of $756.45 Million (americanbankingnews.com) Knoll: Q1 Earnings Enough To Stay Long (seekingalpha.com) ValuEngine Downgrades Steelcase (SCS) to Sell (americanbankingnews.com) Should Stem Cells Spin SA.s (WSE:SCS) Recent Earnings Decline Worry You? (finance.yahoo.com)
Several research analysts have weighed in on the company. ValuEngine lowered Steelcase from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Seaport Global Securities reaffirmed a “neutral” rating on shares of Steelcase in a research report on Monday, March 26th. Finally, Zacks Investment Research raised Steelcase from a “sell” rating to a “hold” rating in a research report on Wednesday, March 28th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $16.00.
Best Biotech Stocks To Invest In Right Now: Express-1 Expedited Solutions Inc.(XPO)
Advisors’ Opinion:
- [By ]
TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer analyzes Thursday’s trending stocks from the floor of the New York Stock Exchange including Macy’s (M) , Amazon (AMZN) , Etsy (ETSY) , XPO Logistics (XPO) and Groupon (GRPN) .
- [By Jeremy Bowman]
Somebody’s got to deliver all of those products that we’re ordering online, and increasingly, that somebody isXPO Logistics(NYSE:XPO). The freight and logistics company has become the leader in last-mile delivery of heavy goods like furniture and appliances, making it a key partner of retailers like Amazon, IKEA,Wayfair, and Home Depot.
- [By ]
For his final “Executive Decision” segment, Cramer also checked in with Brad Jacobs, chairman and CEO of XPO Logistics (XPO) , the transportation provider with shares up 16% in 2018.
- [By ]
TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer said XPO Logistics (XPO) is a remarkable company.
Cramer said UPS (UPS) has labor problems and people think FedEx (FDX) is expensive. “XPO has got a lot of things that they can do,” Cramer said. “They’re in M&A mode.”
- [By ]
XPO Logistics (XPO) : “This stock just won’t come down. “
Over on Real Money, Cramer talks about how to trade the highly unlikely deal between Sprint (S) and T-Mobile (TMUS) . Get more of his insights with a free trial subscription to Real Money.
- [By Rich Duprey, Nicholas Rossolillo, and Maxx Chatsko]
Yet finding the best stocks to buy and hold isn’t easy. So to help get you started, we asked three Foolish investors to pick a growth stock that they believe investors would be wise to buy now and hold for the long term. Read on to learn why they like SunPower (NASDAQ:SPWR), salesforce.com (NYSE:CRM), and XPO Logistics (NYSE:XPO).
